Bafna Pharmaceuticals Limited (BAFNAPH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bafna Pharmaceuticals Limited (BAFNAPH) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs93.12 Million ≈ $1.01 Million USD) by net assets (Rs912.28 Million ≈ $9.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bafna Pharmaceuticals Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Bafna Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Bafna Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bafna Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bafna Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Abnova Taiwan Corp
TW:4133
|
0.010x |
|
Infrea AB
ST:INFREA
|
-0.046x |
|
The Beachbody Company, Inc.
NASDAQ:BODI
|
-0.038x |
|
BG Staffing Inc
NYSE:BGSF
|
0.042x |
|
Globetronics Tech Bhd
KLSE:7022
|
-0.016x |
|
Gold Strike Resources Corp.
V:GSR
|
-2.876x |
|
Aviation Links Ltd
TA:AVIA
|
0.028x |
|
German High Street Properties A/S Class B
CO:GERHSP
|
0.009x |
Annual Cash Flow Conversion Efficiency for Bafna Pharmaceuticals Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Bafna Pharmaceuticals Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see BAFNAPH market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs1.00 Billion ≈ $10.83 Million |
Rs118.27 Million ≈ $1.28 Million |
0.118x | -48.72% |
| 2025-03-31 | Rs848.07 Million ≈ $9.17 Million |
Rs195.29 Million ≈ $2.11 Million |
0.230x | +96.27% |
| 2024-03-31 | Rs808.39 Million ≈ $8.74 Million |
Rs94.85 Million ≈ $1.03 Million |
0.117x | +74.02% |
| 2023-03-31 | Rs734.55 Million ≈ $7.94 Million |
Rs49.52 Million ≈ $535.59K |
0.067x | -57.06% |
| 2022-03-31 | Rs619.64 Million ≈ $6.70 Million |
Rs97.28 Million ≈ $1.05 Million |
0.157x | +165.49% |
| 2021-03-31 | Rs567.71 Million ≈ $6.14 Million |
Rs-136.09 Million ≈ $-1.47 Million |
-0.240x | +64.19% |
| 2020-03-31 | Rs511.95 Million ≈ $5.54 Million |
Rs-342.68 Million ≈ $-3.71 Million |
-0.669x | -606.06% |
| 2019-03-31 | Rs188.52 Million ≈ $2.04 Million |
Rs-17.87 Million ≈ $-193.28K |
-0.095x | +49.95% |
| 2018-03-31 | Rs372.02 Million ≈ $4.02 Million |
Rs-70.47 Million ≈ $-762.14K |
-0.189x | -742.20% |
| 2017-03-31 | Rs421.12 Million ≈ $4.55 Million |
Rs-9.47 Million ≈ $-102.44K |
-0.022x | -242.15% |
| 2016-03-31 | Rs575.71 Million ≈ $6.23 Million |
Rs9.11 Million ≈ $98.52K |
0.016x | -89.21% |
| 2015-03-31 | Rs727.13 Million ≈ $7.86 Million |
Rs106.65 Million ≈ $1.15 Million |
0.147x | +536.93% |
| 2014-03-31 | Rs697.48 Million ≈ $7.54 Million |
Rs16.06 Million ≈ $173.70K |
0.023x | -95.71% |
| 2013-03-31 | Rs683.04 Million ≈ $7.39 Million |
Rs366.32 Million ≈ $3.96 Million |
0.536x | +460.94% |
| 2012-03-31 | Rs646.17 Million ≈ $6.99 Million |
Rs-96.01 Million ≈ $-1.04 Million |
-0.149x | -26.74% |
| 2011-03-31 | Rs541.89 Million ≈ $5.86 Million |
Rs-63.53 Million ≈ $-687.07K |
-0.117x | -708.49% |
| 2010-03-31 | Rs410.05 Million ≈ $4.43 Million |
Rs-5.95 Million ≈ $-64.31K |
-0.015x | +96.00% |
| 2009-03-31 | Rs385.23 Million ≈ $4.17 Million |
Rs-139.82 Million ≈ $-1.51 Million |
-0.363x | -105.51% |
| 2008-03-31 | Rs118.55 Million ≈ $1.28 Million |
Rs-20.94 Million ≈ $-226.43K |
-0.177x | -115.97% |
| 2007-03-31 | Rs91.39 Million ≈ $988.34K |
Rs101.06 Million ≈ $1.09 Million |
1.106x | +1151.53% |
| 2006-03-31 | Rs56.78 Million ≈ $614.05K |
Rs-5.97 Million ≈ $-64.57K |
-0.105x | +83.71% |
| 2005-03-31 | Rs42.55 Million ≈ $460.13K |
Rs-27.46 Million ≈ $-297.02K |
-0.646x | -- |
About Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences … Read more